<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Nasdaq Trade System - Neurocrine Biosciences, Inc. - Common Stock</title>
    <!-- Latest compiled and minified CSS -->
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/css/bootstrap.min.css" rel="stylesheet"
          integrity="sha384-4Q6Gf2aSP4eDXB8Miphtr37CMZZQ5oXLH2yaXMJ2w8e2ZtHTl7GptT4jmndRuHDT" crossorigin="anonymous">
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/js/bootstrap.bundle.min.js"
            integrity="sha384-j1CDi7MgGQ12Z7Qab0qlWQ/Qqz24Gc6BM0thvEMVjHnfYGF0rmFCozFSxQBxwHKO"
            crossorigin="anonymous"></script>
    <meta name="theme-color" content="#712cf9">
</head>

<body>
<header class="navbar sticky-top bg-dark flex-md-nowrap p-0 shadow" data-bs-theme="dark"><a
        class="navbar-brand col-md-3 col-lg-2 me-0 px-3 fs-6 text-white" href="#">Nasdaq Trade system</a>
</header>


<div class="container-fluid">
    <div class="row">

        <main class="col-md-9 ms-sm-auto col-lg-10 px-md-4">
            <a href="../GameResult.html">Back</a>
            <h1>Neurocrine Biosciences, Inc. - Common Stock</h1>
            <img src="NBIX.png" class="img-fluid">
            
            <div class="table-responsive small">
                <table class="table table-striped table-sm">
                    <thead>
                    <tr>
                        <th scope="col">ExecutedOn</th>
                        <th scope="col">Company</th>
                        <th scope="col">Listing</th>
                        <th scope="col">Amount</th>
                        <th scope="col">AtPrice</th>
                        <th scope="col">Total</th>
                    </tr>
                    </thead>
                    <tbody>
                    <tr scope="row">
                        <td>09-05-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>586</td>
                        <td>$75.79</td>
                        <td>$44,412.94</td>
                    </tr>
                    <tr scope="row">
                        <td>10-05-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>-586</td>
                        <td>$82.22</td>
                        <td>-$48,180.92</td>
                    </tr>
                    <tr scope="row">
                        <td>04-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>4142</td>
                        <td>$95.93</td>
                        <td>$397,342.06</td>
                    </tr>
                    <tr scope="row">
                        <td>05-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>-4142</td>
                        <td>$104.04</td>
                        <td>-$430,933.68</td>
                    </tr>
                    <tr scope="row">
                        <td>25-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>6865</td>
                        <td>$104.30</td>
                        <td>$716,019.52</td>
                    </tr>
                    <tr scope="row">
                        <td>26-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>-6865</td>
                        <td>$104.87</td>
                        <td>-$719,932.57</td>
                    </tr>
                    <tr scope="row">
                        <td>29-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>16691</td>
                        <td>$102.76</td>
                        <td>$1,715,167.20</td>
                    </tr>
                    <tr scope="row">
                        <td>30-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>-16691</td>
                        <td>$106.21</td>
                        <td>-$1,772,751.09</td>
                    </tr>
                    <tr scope="row">
                        <td>05-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>17307</td>
                        <td>$108.65</td>
                        <td>$1,880,405.58</td>
                    </tr>
                    <tr scope="row">
                        <td>06-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>-17307</td>
                        <td>$111.38</td>
                        <td>-$1,927,653.61</td>
                    </tr>
                    <tr scope="row">
                        <td>01-11-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>24177</td>
                        <td>$119.36</td>
                        <td>$2,885,766.73</td>
                    </tr>
                    <tr scope="row">
                        <td>02-11-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>-24177</td>
                        <td>$122.06</td>
                        <td>-$2,951,044.56</td>
                    </tr>
                    <tr scope="row">
                        <td>17-11-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>46125</td>
                        <td>$115.06</td>
                        <td>$5,307,142.39</td>
                    </tr>
                    <tr scope="row">
                        <td>18-11-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>-46125</td>
                        <td>$120.16</td>
                        <td>-$5,542,380.17</td>
                    </tr>
                    <tr scope="row">
                        <td>21-12-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>83233</td>
                        <td>$120.34</td>
                        <td>$10,016,258.92</td>
                    </tr>
                    <tr scope="row">
                        <td>22-12-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Neurocrine Biosciences, Inc. - Common Stock</td>
                        <td>-83233</td>
                        <td>$122.40</td>
                        <td>-$10,187,719.33</td>
                    </tr>
                    </tbody>
                </table>
            </div>
        </main>
    </div>
</div>
</body>
</html>